IABP辅助急诊介入治疗心肌梗死患者住院死亡的危险因素

目的探讨主动脉内球囊反搏(IABP)辅助下行急诊经皮冠状动脉介入治疗(PCI)的ST段抬高型心肌梗死(STEMI)患者住院死亡的危险因素。方法入选2010年1月至2014年9月在IABP辅助下行急诊PCI的STEMI患者共91例,分为住院存活组75例和死亡组16例,比较两组患者的临床资料和冠状动脉病变特点,多因素回归分析探讨住院死亡的危险因素。结果与存活组相比,死亡组患者平均年龄大,Killips心功能分级高(P0.05),但性别、吸烟、高血压病、高脂血症、糖尿病、既往PCI史、心肌梗死史、总缺血时间、术前IABP植入比例等无统计学差异。多因素回归分析显示,PCI术后TIMI 3级血流(OR=0.462,P0.05)对患者住院死亡是保护性因素,年龄越大(OR=1.081,P0.05)、术后CK-MB峰值越高(OR=1.003,P0.05)、合并左主干病变(OR=7.273,P0.05)、Killips分级Ⅲ/Ⅳ级(OR=6.703,P0.01)是患者住院死亡的独立危险因素。结论对于IABP辅助下行急诊PCI的STEMI患者,术后梗死相关血管TIMI 3级血流可以降低死亡率,而合并Killips分级Ⅲ/Ⅳ级、左主干病变、年龄越大、术后CK-MB峰值越高,预示住院死亡率越高。     

老年ST段抬高型心肌梗死患者经皮冠状动脉介入时机对左心功能的影响

目的 探讨经皮冠状动脉介入(PCI)时机对老年ST段抬高型心肌梗死(STEMI)患者左心功能的影响.方法 92例新发老年STEMI患者施行PCI治疗,根据发病距梗死相关血管(IRA)开通时间分为两组,12 h内为急诊PCI组(56例),12 h后为择期PCI组(36例).比较两组TIMI血流情况,术后Killip心功能分级及术前后超声心动图相关指标的改善情况.结果 两组术前超声心动图指标无显著差异(P＞0.05),急诊PCI组TIMI 3级血流患者比例高于择期PCI组(P＜0.05),两组术后1、3个月时左心功能均较术前改善(P＜0.05),急诊PCI组术后1、3个月超声心动图指标明显优于择期PCI组(P＜0.05).结论 急诊PCI及择期PCI均能改善老年STEMI患者左心功能,而急诊PCI效果更为显著.     

急诊经皮冠状动脉介入治疗中梗死相关动脉再通后低血压的相关因素分析

目的探讨急性心肌梗死(acute myocardial infarction,AMI)患者行急诊经皮冠状动脉介入治疗(percutaneous coronary intervention,PCI)术中梗死相关动脉(infarction related artery,IRA)再通后低血压的相关因素。方法回顾性分析中国医科大学第一医院自2003年1月至2006年9月首次AMI接受急诊PCI的245例连续性患者的临床和冠状动脉造影资料。排除急诊PCI术中再灌注后血压高于正常者27例,将218例患者按再灌注后血压情况分为两组,即低血压组102例和正常血压组116例,运用Logistic回归分析低血压的相关因素。结果低血压组中年龄在60岁以上、PCI前Killip分级≥2级、下壁或右室梗死、右冠状动脉病变、病变血管为近段或完全闭塞病变、多支血管病变和IRA开通后TIMI血流≤1级的发生率明显高于正常血压组(分别为56.9%比37.9%,36.3%比22.4%,50.8% 13.6%比28.8% 1.6%,54.9%比18.1%,60.8% 87.3%比43.1% 66.4%,68.6%比54.3%和15.7%比7.8%),且低血压组患者的住院死亡率明显增高(11.8%比1.7%),差异均有统计学意义(P均<0.05)。而Logistic回归分析表明:低血压的相关因素为年龄≥60岁、Killip≥2级、下壁梗死、右冠状动脉病变、近段血管病变及完全闭塞病变(P<0.05,OR>1)。结论60岁以上老年人、Killip分级≥2级、下壁梗死、右冠状动脉病变、病变血管为近段或完全闭塞病变是AMI患者急诊PCI术中IRA再通后低血压的危险因素,而且低血压的发生明显增加患者的住院死亡率。     

急性ST段抬高心肌梗死行急诊经皮冠状动脉介入术无复流影响因素探讨

目的:探讨急性ST段抬高性心肌梗死(STEMI)患者,行经皮冠状动脉介入术(PCI)时无复流现象的发生率及其相关危险因素。方法:选择本院2010年8月至2013年3月之间,STEMI行急诊PCI术的患者458例,分成无复流(慢血流)组及血流良好组,观察一般临床基线,冠状动脉造影血管病变特点等资料之间的差异。结果:63例(13.8%)患者于PCI时出现了无复流/慢血流现象。两组在性别、年龄、族别、出现症状至PCI时间,既往是否存在吸烟史、高血压史、血脂异常等高危因素以及靶血管部位、血管长度及直径等,差异均无统计学意义(P0.05),而在既往存在心肌梗死病史,糖尿病患者中,无复流/慢血流较血流正常组是增高的。在术前心肌梗死溶栓分级(TIMI)血流≤1级的AMI患者以及靶病变PCI中存在血栓负荷者出现无复流/慢血流组较血流正常组高,两组之间存在差异(P0.05)。结论:STEMI急诊PCI术后无复流现象的出现与既往存在心肌梗死、糖尿病病史,术前TIMI血流≤1的AMI患者以及靶病变PCI中存在血栓负荷者可能有关。     

老年急诊经皮冠状动脉介入术后无复流的危险因素分析

【】目的：探讨老年急性心肌梗死患者急诊经皮冠状动脉介入(PCI)术后出现无复流的相关危险因素。方法：302例行急诊PCI术的老年急性心肌梗死患者根据PCI术后TIMI血流分级分为无复流组和正常血流组,比较两组患者临床基线资料,造影结果及手术相关资料的差异,应用logistic逐步回归分析老年急诊PCI术后出现无复流的影响因素。结果：老年急诊PCI术后无复流发生率为24.8%(75/302),两组患者间的症状至PCI时间,既往糖尿病人数,术前心功能Killip分级,术前收缩压,术前TIMI血流≤1级人数,病变长度,球囊扩张次数,高血栓负荷人数比较差异有统计学意义(P<0.05)。logistic多元逐步回归分析显示：症状至PCI时间>6h(OR=2.119,P=0.018),高血栓负荷(OR=1.941,P=0.022),术前TIMI血流≤1级(OR=1.718,P=0.009),球囊扩张次数(OR=1.071,P=0.015)是老年急诊PCI术后发生无复流的独立危险因素。结论：可根据老年急性心肌梗死患者临床、造影及手术时的情况来预测急诊PCI术后是否发生无复流现象。     

慢性闭塞病变患者介入治疗后心肌血流和心电图及心功能变化

目的探讨慢性冠状动脉闭塞(CTO)病变患者PCI后梗死相关动脉(IRA)闭塞血管TIMI血流和心肌灌注(TMP)血流的变化;了解CTO病变PCI后心电图、心功能的变化。方法选择心绞痛或心电图异常的住院患者42例行冠状动脉造影检查,确诊为CTO病变,进行PCI支架置入术。分析术前、术后IRA的TIMI血流、TMP血流、心电图和心功能的变化。结果 CTO病变PCI后IRA的TIMI血流、TMP血流3级者分别为36例(85.7%)和25例(59.5%);PCI前、后心绞痛、心功能比较差异有统计学意义(P<0.05,P<0.01)。心电图Q波、ST段、T波异常与相关CTO均<30%,PCI前、后心电图显示Q波、ST段、T波异常共40次,前、后对比共17次(42.5%),无异常者23次(57.5%)。结论 CTO病变行PCI后,对冠状动脉再通、改善心肌血流灌注、改善心功能、缓解心绞痛症状以及对心电图异常的改变均有意义。     

替罗非班联合冠脉内血栓导管抽吸对急诊ST段抬高心肌梗死患者PCI术血运重建的影响

目的探讨替罗非班联合冠脉内血栓导管抽吸对急诊ST段抬高心肌梗死(STEMI)患者标准经皮冠状动脉介入治疗(PCI)术血运重建的影响。方法 98例STEMI患者随机分为PCI+血栓抽吸+替罗非班组(A组),PCI+替罗非班组(B组)。观察两组患者血管再通时即刻的血流血管心肌梗死溶栓(TIMI)分级、TIMI心肌灌注(TMPG)分级、术后2h心电图ST段回落大于50%的发生率、心肌磷酸激酶同工酶(CK-MB)峰值、CK-MB峰值时间,术后2h胸痛缓解率再灌注心律失常发生率。结果 A组心肌灌注明显增加,TIMI血流及TMPG血流明显改善,术后2h心电图ST段回落大于50%的发生率、CK-MB峰值、CK-MB峰值时间,术后2h内胸痛缓解率及再灌注心律失常发生率优于对照组。结论血栓抽吸与替罗非班联合治疗可改善急性ST段抬高性心肌梗死患者冠脉内血栓病变的血栓负荷、冠状动脉血流、心肌灌注,改善患者预后。     

血栓抽吸导管在急性ST段抬高性心肌梗死急诊介入治疗中的应用

目的探讨血栓抽吸导管在急性ST段抬高性心肌梗死(STEMI)急诊介入治疗(PCI)中应用的有效性及安全性。方法选择2012年1月—2013年12月入住我院心内科行急诊PCI治疗的急性STEMI 120例,冠状动脉造影(CAG)术提示血栓积分≥2分的患者行血栓抽吸和PCI治疗为A组(65例),CAG术提示血栓积分2分的患者直接行PCI治疗为B组(55例),比较两组术后TIMI血流、心肌染色分级(MBG)、左室射血分数(LVEF)、心肌酶峰时间、术后2h心电图ST段回落≥50%比率、院内死亡率。结果 A组TIMI血流分级、MBG分级高于B组,有统计学意义(P0.05),A组心肌酶达峰时间低于B组,有统计学意义(P0.05),两组住院期间死亡率、术后LVEF、术后两小时心电图ST段回落≥50%比率无统计学意义(P0.05)。结论血栓抽吸导管在血栓高负荷的急性STEMI急诊PCI治疗中,能改善急性STEMI患者的TIMI血流、MBG分级,且具有良好的安全性及有效性。     

提前应用比伐芦定在直接经皮冠状动脉介入治疗中的疗效与安全性研究

目的:探究急诊介入术前提前应用比伐芦定与常规用药相比在直接经皮冠状动脉介入(PCI)治疗中的疗效及安全性。方法:回顾性分析103例接受直接PCI的急性ST段抬高型心肌梗死(STEMI)患者,分为提前比伐芦定组(治疗组,49例)和常规比伐芦定组(对照组,54例)。所有患者在发病12 h内行急诊PCI术。治疗组在患者及家属同意行急诊PCI时即给予比伐芦定治疗,首先静脉给予比伐芦定负荷量(0.75 mg/kg),然后以1.75 mg·kg~(-1)·h~(-1)持续静脉泵入至术后4 h。对照组在急诊PCI进入导管室穿刺时给予比伐芦定,给药方案同治疗组。观察2组患者造影时罪犯血管血流TIMI分级,校正的TIMI血流帧数计数,出血发生率,术后及随访6个月时死亡、非致死性心肌梗死、靶血管再次血运重建、支架血栓、心功能分级、左室射血分数、出血事件发生率。结果:治疗组冠状动脉(冠脉)造影所见罪犯血管TIMI血流分级优于对照组,0级血流比例低于对照组(44.9%∶74.1%,P0.05),术后血流帧数优于对照组[(31.4±8.9)帧∶(43.6±9.2)帧,P0.05]。2组出血事件发生率与随访6个月时死亡、非致死性心肌梗死、靶血管再次血运重建、心功能分级及左室射血分数均差异无统计学意义。结论:术前及早应用比伐芦定可改善未能尽早行PCI的急性STEMI患者的冠脉血流与心肌灌注,从而部分抵消因PCI延迟导致的心功能、左室射血分数下降及其他不良事件的发生,且不增加出血事件发生率。     

主动脉内球囊反搏在急性心肌梗死合并泵衰竭急诊介入中的辅助治疗

目的　评价在急性心肌梗死 (AMI)合并泵衰竭急诊介入中辅以主动脉内球囊反搏(IABP)治疗的安全性及有效性。方法　对 87例合并严重泵衰竭甚或心源性休克的AMI患者行急诊介入治疗。将 2 1例 (2 4% )同时接受IABP辅助治疗的患者设为IABP组 (A组 ) ,另 6 6例 (76 % )设为对照组 (B组 )。比较两组临床特征、冠状动脉造影情况及住院期的临床疗效。结果　年龄、性别、发病初始至导管室时间、心肌梗死部位、冠状动脉病变支数、具体梗死相关动脉 (IRA)及血管重建术前梗死相关动脉血流TIMI分级等指标 ,A、B两组之间无统计学差异。心功能分级 (Killip分级 ) ,A组较B组严重 ;而住院期间 ,A组死亡率及血管再闭塞事件较B组明显降低。结论　对于高危AMI合并泵衰竭 ,尤其心源性休克的患者 ,在行急诊介入时 ,IABP的辅助使用明显降低住院期死亡率 ,减少血管再闭塞率 ,提高手术成功率 ,其远期预后有待进一步随访。     

Prognostic significance of atrial fibrillation/atrial flutter in patients with acute myocardial infarction treated with percutaneous coronary intervention

Atrial fibrillation (AF) is a frequent complication after acute myocardial infarction (AMI) that has been associated with increased in-hospital and long-term mortality rates in the prethrombolytic and thrombolytic eras. Current therapies, including percutaneous coronary intervention (PCI), are effective in reducing mortality in patients with AMI. However, little is known concerning the incidence and prognostic significance of AF in patients with AMI who are treated with PCI. We evaluated 2,475 consecutive patients with AMI who underwent PCI within 24 hours after onset and who were enrolled in the Osaka Acute Coronary Insufficiency Study. Patients were categorized into 2 groups according to the presence of AF or atrial flutter. The incidence of AF was 12.0%. Patients with AF were older, were in higher Killip classes, had higher rates of previous myocardial infarction and previous cerebrovascular disease, had systolic blood pressure of <100 mm Hg and heart rates of > or =100 beats/min, multivessel disease, and had poorer reperfusion of the infarct-related artery than those without AF. Patients with AF had higher in-hospital (16.0% vs 6.7%, p <0.001) and 1-year (18.9% vs 7.9%, p <0.001) mortality than those without AF. Multivariate Cox regression analysis revealed that AF was an independent predictor of 1-year mortality (hazard ratio 1.64, 95% confidence interval 1.05 to 2.55) but was not a predictor of in-hospital mortality. AF is a common complication in patients with AMI who are treated with PCI and independently influences 1-year mortality.     

急性心肌梗死并发心房颤动/心房扑动的影响因素及预后分析

目的分析急性心肌梗死(AMI)患者合并心房颤动(atrial fibrillation,Af)/心房扑动(atria flutter,AF)的发病率、临床特点、影响因素及其对院内死亡的影响。方法将我院收治的653例AMI患者分为Af/AF组(61例)及无Af/AF组(592例),分析发生Af/AF的相关危险因素;再根据是否在院内死亡分为院内死亡组(64例)及未死亡组(589例),评估Af/AF对AMI患者院内死亡的影响。结果AMI患者初发Af/AF的发生率为9.3%。单因素分析显示,Af/AF组与无Af/AF组在年龄、性别、入院时心率、心肌梗死范围、Killip分级、左心室射血分数、入院时血肌酐水平及血红蛋白水平均有显著性差异(P<0.05)。Af/AF组与无Af/AF组多因素logistic回归分析显示,多部位心肌梗死、女性是影响AMI患者发生Af/AF的最主要独立危险因素;院内死亡组与未死亡组多因素lo-gistic回归分析显示,Af/AF是影响AMI患者院内死亡的独立危险因素。结论Af/AF是AMI患者常见的并发症,合并Af/AF的患者住院期间的预后更差。     

Prognostic significance of new atrial fibrillation and its relation to heart failure following acute myocardial infarction

BACKGROUND: New-onset atrial fibrillation (AF) after acute myocardial infarction (AMI) frequently occurs in association with postinfarction complications, particularly with heart failure (HF). AIMS: To evaluate whether postinfarction HF is associated with the subsequent development of AF and whether AF independently predicts poorer prognosis. METHODS AND RESULTS: We examined 650 patients with AMI and compared patients with AF (n=320) to those without (n=330). AF patients were classified as either early AF (n=208)-patients who developed AF within 24 h of symptom onset or late AF (n=112)-patients who had AF thereafter. We compared outcomes between these groups, adjusting for differences in baseline characteristics and postinfarction HF. Heart failure was the most important predictor of AF. In most patients, AF occurred secondary to HF. AF patients had poorer outcomes, including higher in-hospital and 7-year mortality. After multivariate adjustment, overall, AF was not an independent predictor of in-hospital [odds ratio (OR)=0.70) and 7-year [relative risk (RR)=1.14] mortality, but late AF remained an independent predictor of 7-year (RR=2.48, 95% confidence interval, 1.26-4.87) mortality. CONCLUSIONS: Heart failure mostly preceded the occurrence of new-onset atrial fibrillation after acute myocardial infarction, but only late atrial fibrillation was independently related to long-term mortality.     

Plasminogen activator inhibitor-1 in patients with atrial arrhythmias during acute myocardial infarction, treated with streptokinase.

Atrial arrhythmias (AA), especially atrial fibrillation (AF), during acute myocardial infarction (AMI) are often associated with increased mortality and heart failure. Impaired fibrinolysis with elevated plasminogen activator inhibitor-1 (PAI-1) activity is associated with resistance to fibrinolytic therapy in AMI patients, but it is also found in patients with AF. Our aim was a prospective study of the role of pre-treatment PAI-1 levels for the presence of AA in AMI patients and the influence of AA on in-hospital mortality. In 116 AMI patients, treated with streptokinase, pre-treatment PAI-1 levels were estimated by the chromogenic method (normal levels, 0.3-3.5 U/ml) and in-hospital AA were assessed as atrial fibrillation, flutter and/or tachycardias. Between patients with and without AA, a significant difference was observed in mean pre-treatment PAI-1 levels, in several in-hospital complications and mortality (24 versus 4.4%; P < 0.01; odds ratio, 6.45; 95% confidence interval, 1.66-25.0). The PAI-1 level > 7 U/ml was the most significant independent pre-treatment risk factor for AA (P < 0.05; odds ratio, 3.5; 95% confidence interval, 1.15-10.6). We conclude that AA were a significant risk for in-hospital mortality of AMI patients, treated with streptokinase. A pre-treatment PAI-1 level > 7 U/ml was the most significant pre-treatment risk for AA in these patients.     

急性心肌梗死并发心房颤动的临床意义

目的 观察急性心肌梗死并发心房颤动的临床意义。方法 比较急性心肌梗死心房颤动组20例和非心房颤动组132例的心力衰竭发生率及死亡率。结果 急性心肌梗死心房颤动组心力衰竭发生率（90．0％），及死亡率（60．0％）均明显高于非心房颤动组（31．1％，15．1％，P〈0．01）。结论 急性心肌梗死并发心房颤动预后较差。     

急性心肌梗死并发心房颤动临床分析

目的观察急性心肌梗死并发心房颤动的临床意义。方法比较急性心肌梗死患者心房颤动组25例和非心房颤动组120例的冠状动脉病变程度、心力衰竭发生率及病死率。结果心房颤动组与非心房颤动组比较,心力衰竭发生率(32%比11%)及病死率(36%比12%)前组均高于后组(P<0.05)。心房颤动组冠状动脉的2支以上冠状动脉病变发生率高(P<0.05)。心房颤动早发亚组梗死相关动脉以右冠状动脉近端阻塞为主(P<0.05),心房颤动迟发亚组梗死相关动脉以左冠状动脉前降支阻塞为多。结论急性心肌梗死并发心房颤动预后差。     

Significance of recurrences of new atrial fibrillation in acute myocardial infarction

BACKGROUND: Although new-onset atrial fibrillation (AF) frequently recurs following the acute myocardial infarction, the significance of AF recurrences is unknown. OBJECTIVE: The objective of the present study was to evaluate the incidence, clinical predictors and prognostic significance of AF recurrences following the acute myocardial infarction. METHODS AND RESULTS: A total of 320 consecutive patients with AF following the acute myocardial infarction were evaluated and the patients with AF recurrences were compared to those with single episodes of AF in whom AF did not recur after restoration of sinus rhythm. The incidence of AF recurrences was 22.5%. AF recurrences were highly associated with congestive heart failure and worse Killip class was identified as the most important predictor of AF recurrences. Patients with AF recurrences had poorer outcome, including higher in-hospital (36.1% versus 12.9%) and 7-year (68.2% versus 48.6%) mortality. After multivariate adjustment, AF recurrence remained an independent predictor of in-hospital [odds ratio (OR) = 3.08, 95% confidence interval (CI), 1.45-6.53, p = 0.001], and 7-year [relative risk (RR) = 1.52, 95% CI, 1.00-2.31, p = 0.026] mortality. CONCLUSION: New-onset AF frequently recurs following the acute myocardial infarction and our analysis demonstrated that recurrences of AF independently predicted in-hospital and long-term mortality.     

起搏术后心房颤动的影响因素及心房颤动与心钠素的关系

目的观察心脏起搏术后发生心房颤动(简称房颤)的影响因素及房颤与血心钠素(ANP)的关系。方法选择安装心脏起搏器的患者103例进行随访,分析房颤与年龄、起搏方式、心律失常类型、左房内径(LAD)、左室射血分数(LVEF)和血ANP的关系。结果①65岁以下患者房颤发生率低于65岁以上组(P<0.05)。②VVI组房颤发生率高于DDD组(P<0.05)。③慢快综合征组房颤发生率较缓慢型病窦综合征和房室传导阻滞组高(P<0.05)。④VVI房颤组术后LAD增大、LVEF下降(P<0.05),VVI房颤组术后与DDD组比较有差异(P<0.05)。⑤VVI房颤组和VVI窦性心律组ANP浓度较DDD组高(P<0.05);各组不同心功能级别(NYHA)之间ANP浓度随着心功能级别的加重而升高。结论长期心脏起搏术后房颤的发生可能与年龄大、VVI起搏、病窦综合征(慢快型)、LAD增大、LVEF降低及ANP浓度升高相关。     

急性心肌梗死恢复期新发房颤的发生率与危险因素

目的 分析急性心肌梗死(AMI)患者恢复期（心肌梗死28 d后）出现新发房颤的发生率与危险因素。方法 回顾性分析2009年6月~2011年6月全部212例因AMI入住长征医院治疗且无房颤病史的患者一般情况,相关检查结果,以及心肌梗死1年内后续治疗、转归情况,并对可能影响患者恢复期新发房颤的因素进行logistic回归模型分析。结果 多因素logistic回归分析表明,高龄(P<0.05,OR=5.61),高血压病（P<0.05,OR=5.89）,左心室射血分数（LVEF）降低(P<0.01,OR=6.3),未行急诊经皮冠状动脉介入（PCI）术（P<0.01,OR=6.01）,糖尿病（P<0.05,OR=3.59）以及出院后无法耐受β受体阻滞剂治疗（P<0.01,OR=6.1）等是新发房颤的危险因素。结论 AMI患者恢复期出现新发房颤的危险因素为高龄,高血压病,LVEF降低,未行急诊PCI术,糖尿病以及出院后无法耐受β受体阻滞剂治疗。     

Association between lifetime risk of atrial fibrillation and mortality in the oldest old

Background

Age is the strongest predictor of atrial fibrillation (AF), yet little is known about AF incidence in the oldest old.

Hypothesis

AF incidence declines after age 90 years, and morbidity is compressed into a brief period at the end of life.

Methods

In this retrospective, longitudinal cohort study of patients (born 1905–1935), we examined cumulative lifetime incidence of AF and its impact on mortality. Data included records from 1 062 610 octogenarians, 317 161 nonagenarians, and 3572 centenarians. Kaplan–Meier curves were used to estimate cumulative incidence of AF by age group, incidence rates were compared using log‐rank tests, and Cox proportional hazards model was used to estimate unadjusted hazard ratios. The primary outcome was AF incidence at age > 80 years; the secondary outcome was mortality.

Results

The cumulative AF incidence rate was 5.0% in octogenarians, 5.4% in nonagenarians, and 2.3% in centenarians. Octogenarians and nonagenarians had a higher risk of AF incidence compared to centenarians (adjusted hazard ratio 8.74, 95% confidence interval [CI]: 6.31–12.04; and 2.98, 95% CI: 2.17–4.1, respectively). The lowest hazard ratio for mortality in patients with AF compared to those without was 2.3 (95% CI: 2.3–2.4) in patients who were on antiplatelet and anticoagulant medication and had a score of 0 on the Elixhauser comorbidity index score.

Conclusions

Although AF incidence increased with age, being a centenarian was associated with reduced incidence and compression of morbidity. Patients with AF had a higher adjusted mortality rate. However, data suggest that a regimen of anticoagulants and antiplatelets may reduce risk of mortality in patients over 80 with an AF diagnosis.